The CDC expanded RSV vaccine recommendations to include adults aged 50 and above who have underlying health conditions ...

Moderna faces weak post-pandemic vaccine demand and financial struggles, with limited near-term catalysts. Click here to read ...

Research from the UK Health Security Agency (UKHSA) has found the RSV vaccine is 72% effective in preventing hospitalisation ...

Pregnant individuals commonly reported hesitancy toward RSVpreF and nirsevimab, indicating the need for efforts to promote the safety and uptake of RSV immunization.

In babies, RSV is a common cause of a type of chest infection called bronchiolitis. Last week, the UK Health Security Agency ...

MAINE, USA — The federal government is pulling the plug on half a billion dollars in mRNA vaccine research funding — a move ...

Pregnant women in England urged to get the RSV vaccine from 28 weeks to protect babies from respiratory syncytial virus, says NHS chief ...

Secretary Robert F. Kennedy Jr. said his department would slash funding for mRNA vaccine research and shift its focus to ...

Multiple Massachusetts-based vaccine companies, including Moderna, are affected by U.S. Health and Human Services Secretary ...

Robert F. Kennedy Jr. announced the cancellation of 22 mRNA vaccine projects worth $500 million, halting efforts to develop ...

"A bad day for science, and huge blow to our national security, this decision will have dangerous repercussion," one scientist said.